Vanda Pharmaceuticals buy Truist Financial Co.
Start price
05.03.26
/
50%
€6.80
Target price
05.03.27
€15.49
Performance (%)
-21.76%
Price
22.05.26
€5.32
Summary
This prediction is currently active. The price of Vanda Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.76%. This prediction currently runs until 05.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | -1.664% | -1.664% |
| iShares Core DAX® | 3,81 % | 2,25 % |
| iShares Nasdaq 100 | 1,29 % | 10,52 % |
| iShares Nikkei 225® | 2,01 % | 7,25 % |
| iShares S&P 500 | 0,99 % | 5,71 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (VNDA) is now covered by Truist Financial Corporation. They set a "buy" rating and a $18.00 price target on the stock.
Ratings data for VNDA provided by MarketBeat